NKTR-102
15-102-14
Phase 3 small_molecule completed
Quick answer
NKTR-102 for Metastasis is a Phase 3 program (small_molecule) at NEKTAR THERAPEUTICS with 1 ClinicalTrials.gov record(s).
Program details
- Company
- NEKTAR THERAPEUTICS
- Indication
- Metastasis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed